All News
Large GWAS Study Reveals Genetic Basis for Osteoarthritis Phenotypes
Cell has published the results of a multinational, GWAS meta-analyses of 826,690 individuals that included 177,517 osteoarthritis patients, finding 52 previously unknown osteoarthritis (OA) genetic risk variants and linking OA genetic risks with joint distribution and pain
Read Article
Systematic review of dietary interventions for RA - 30 RCTs, 1063 pts; Pain was most reported outcome, sporadic studies showed occ. lowering of ESR, CRP, TNF, Plts, Igs, etc. Few studies show Anti-inflammatory diets may effective lowering DAS in RA https://t.co/B46NrVkwcK
Links:
Dr. John Cush RheumNow ( View Tweet)
#ACR21 is just days away and we want to see your best images of learning virtually, missing a meeting in San Francisco, wellness, break time activities, etc!
Tweet your pic and make sure to include #RheumPix and #ACR21 and we’ll RT our favorites. https://t.co/ey9iZ9QaKO
Dr. John Cush RheumNow ( View Tweet)
QD Clinic - Alopecia Rules
QD Clinic is sponsored by https://t.co/V10S4oVFsv's coverage of #ACR21
https://t.co/8w6xQS5uPz https://t.co/FDvXVNkvVy
Dr. John Cush RheumNow ( View Tweet)
New podcast available for download on RheumNow!
https://t.co/zuowQS3pTK https://t.co/vZeUMgWwEr
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: ACR publishes a "White paper on Antimalarial Cardiac Toxicity"- reviewing drug hx,indications, effects & rare risk of arrhythmias, conduction abnormalities, cardiomyopathy, QTc prolongation. torsade de pointes. No evidence for routine ECG monitoring https://t.co/2aemSKzk3T https://t.co/4CrqO0OKlz
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: The Sacroiliac Joint - some call this a symphysis, but it is an "amphiarthrosis", or sliding joint, with minimal movement; Only the lower 1/3 of the joint is synovial lined -- this is where one should look for sacroiliitis. https://t.co/8uD13h2qHZ https://t.co/D3UERVXrgX https://t.co/2DToXTQCi5
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Platelet-Rich Plasma Injections Fail in Ankle Osteoarthritis
https://t.co/Fmf8f2C3Y4 https://t.co/8Tw4fAhREd
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Systematic review of dsDNA studies (byfluorescence immunoassay) included 1977 total patients, 47% with SLE == over all dsDNA had >90% for specificity and a pooled specificity of 94.7% (95% CI 91.67%-96.67%) https://t.co/Nk8h9fDYpE https://t.co/RcmewQpN7B
Links:
Dr. John Cush RheumNow ( View Tweet)
Way to Go (big) Seoyoung!! https://t.co/G59UTTMTIb
Dr. John Cush RheumNow ( View Tweet)
Congrats!!! https://t.co/v6EUyDJ5lJ
Dr. John Cush RheumNow ( View Tweet)
Primary care docs: please remember that it is not enough just to treat the acute gouty episode. This truly is a chronic debilitating disease #MedEd #gout https://t.co/lXTIqZXA1m
Yousaf Ali MD yousafali_md ( View Tweet)
Beautiful, isn’t it? https://t.co/Ga0840KBcW
Alla Ayten alla_ajten ( View Tweet)
If you see a patient with fatigue and arthralgias please screen for depression before you order a battery of serologies. Pain is a common feature of depression #MedEd https://t.co/0FCugZRbgI
Yousaf Ali MD yousafali_md ( View Tweet)
ICYMI:New Download Available!
FDA EUA for Baricitinib in COVID
https://t.co/yTQLb7DDvR https://t.co/p6NPCXa0Fn
Links:
Dr. John Cush RheumNow ( View Tweet)
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow
https://t.co/riyAnrRHhX https://t.co/XIJIMdvQ2g
Links:
Dr. John Cush RheumNow ( View Tweet)
Biologic Use and the Risk of Serious Infection in Psoriasis Patients
https://t.co/zU8ZaYjGyf https://t.co/jpAITJOFpi
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheumatologists are setting cardiology straight about hydroxychloroquine and chloroquine. This, and a special recognition of parent-child rheumatologists, along with the news and articles from this week on RheumNow.
https://t.co/zuowQS3pTK https://t.co/eToS9zjqss
Links:
Dr. John Cush RheumNow ( View Tweet)
BEAT-LUPUS: Sequential Belimumab After Rituximab in SLE
https://t.co/4hUBRnhdhl https://t.co/xj900Vd8qt
Links:
Dr. John Cush RheumNow ( View Tweet)
Nationwide 2 yr F/U study, 11 centers, 300 pts with early (1.2 yrs) systemic sclerosis shows, despite most (2/3) on immunosuppressives, 71% progressed to diffuse SSc, 21% worsen Skin, 23% worse FVC & 6.6% died (cardiac, GI, ILD) https://t.co/UfagmX2S16
Links:
Dr. John Cush RheumNow ( View Tweet)